PURPOSE: Pediatric short bowel syndrome (SBS) remains a management challenge with significant mortality. In 1999, we initiated a multidisciplinary pediatric intestinal rehabilitation program. The purpose of this study was to determine if the multidisciplinary approach was associated with improved survival in this patient population. METHODS: The Center for Advanced Intestinal Rehabilitation includes dedicated staff in surgery, gastroenterology, nutrition, pharmacy, nursing, and social work. We reviewed the medical records of all inpatients and outpatients with severe SBS treated from 1999 to 2006. These patients were compared to a historical control group of 30 consecutive patients with severe SBS who were treated between 1986 and 1998. RESULTS: Fifty-four patients with severe SBS managed by the multidisciplinary program were identified. Median follow-up was 403 days. The mean residual small intestinal length was 70 +/- 36 vs 83 +/- 67 cm in the historical controls (P = NS). Mean peak direct bilirubin was 8.1 +/- 7.9 vs 9.0 +/- 7.4 mg/dL in controls (P = NS). Full enteral nutrition was achieved in 36 (67%) of 54 patients with severe SBS vs 20 (67%) of 30 patients in the control group (P = NS). The overall survival rate, however, was 89% (48/54), which is significantly higher than in the historical controls (70%, 21/30; P < .05). CONCLUSIONS: A multidisciplinary approach to intestinal rehabilitation allows for fully integrated care of inpatients and outpatients with SBS by fostering coordination of surgical, medical, and nutritional management. Our experience with 2 comparable cohorts demonstrates that this multidisciplinary approach is associated with improved survival.
PURPOSE: Pediatric short bowel syndrome (SBS) remains a management challenge with significant mortality. In 1999, we initiated a multidisciplinary pediatric intestinal rehabilitation program. The purpose of this study was to determine if the multidisciplinary approach was associated with improved survival in this patient population. METHODS: The Center for Advanced Intestinal Rehabilitation includes dedicated staff in surgery, gastroenterology, nutrition, pharmacy, nursing, and social work. We reviewed the medical records of all inpatients and outpatients with severe SBS treated from 1999 to 2006. These patients were compared to a historical control group of 30 consecutive patients with severe SBS who were treated between 1986 and 1998. RESULTS: Fifty-four patients with severe SBS managed by the multidisciplinary program were identified. Median follow-up was 403 days. The mean residual small intestinal length was 70 +/- 36 vs 83 +/- 67 cm in the historical controls (P = NS). Mean peak direct bilirubin was 8.1 +/- 7.9 vs 9.0 +/- 7.4 mg/dL in controls (P = NS). Full enteral nutrition was achieved in 36 (67%) of 54 patients with severe SBS vs 20 (67%) of 30 patients in the control group (P = NS). The overall survival rate, however, was 89% (48/54), which is significantly higher than in the historical controls (70%, 21/30; P < .05). CONCLUSIONS: A multidisciplinary approach to intestinal rehabilitation allows for fully integrated care of inpatients and outpatients with SBS by fostering coordination of surgical, medical, and nutritional management. Our experience with 2 comparable cohorts demonstrates that this multidisciplinary approach is associated with improved survival.
Authors: D J Andorsky; D P Lund; C W Lillehei; T Jaksic; J Dicanzio; D S Richardson; S B Collier; C Lo; C Duggan Journal: J Pediatr Date: 2001-07 Impact factor: 4.406
Authors: Kathleen M Gura; Christopher P Duggan; Sharon B Collier; Russell W Jennings; Judah Folkman; Bruce R Bistrian; Mark Puder Journal: Pediatrics Date: 2006-07 Impact factor: 7.124
Authors: J Bueno; S Ohwada; S Kocoshis; G V Mazariegos; I Dvorchik; L Sigurdsson; C Di Lorenzo; K Abu-Elmagd; J Reyes Journal: J Pediatr Surg Date: 1999-01 Impact factor: 2.545
Authors: Daniel J Raiten; Alison L Steiber; Susan E Carlson; Ian Griffin; Diane Anderson; William W Hay; Sandra Robins; Josef Neu; Michael K Georgieff; Sharon Groh-Wargo; Tanis R Fenton Journal: Am J Clin Nutr Date: 2016-01-20 Impact factor: 7.045
Authors: Ana M G A Sant'Anna; Eyad Altamimi; Rose-Frances Clause; Joanne Saab; Heather Mileski; Brian Cameron; Peter Fitzgerald; Guilherme M Sant'Anna Journal: Can J Gastroenterol Date: 2012-05 Impact factor: 3.522
Authors: Patrick J Javid; Sabrina E Sanchez; Susan Jacob; Monica M McNeal; Simon P Horslen; Janet A Englund Journal: J Pediatric Infect Dis Soc Date: 2013-10-14 Impact factor: 3.164
Authors: Bram P Raphael; Paul D Mitchell; Darryl Finkton; Hongyu Jiang; Tom Jaksic; Christopher Duggan Journal: J Pediatr Date: 2015-04-01 Impact factor: 4.406
Authors: Mitchell R Ladd; Cait M Costello; Carolyn Gosztyla; Adam D Werts; Blake Johnson; William B Fulton; Laura Y Martin; Elizabeth J Redfield; Bryan Crawford; Rohan Panaparambil; Chhinder P Sodhi; John C March; David J Hackam Journal: Tissue Eng Part A Date: 2019-09-03 Impact factor: 3.845
Authors: Gillian C Pet; Ryan M McAdams; Lilah Melzer; Assaf P Oron; Simon P Horslen; Adam Goldin; Patrick J Javid Journal: J Pediatr Date: 2018-05-10 Impact factor: 4.406
Authors: Faraz A Khan; Robert H Squires; Heather J Litman; Jane Balint; Beth A Carter; Jeremy G Fisher; Simon P Horslen; Tom Jaksic; Samuel Kocoshis; J Andres Martinez; David Mercer; Susan Rhee; Jeffrey A Rudolph; Jason Soden; Debra Sudan; Riccardo A Superina; Daniel H Teitelbaum; Robert Venick; Paul W Wales; Christopher Duggan Journal: J Pediatr Date: 2015-04-25 Impact factor: 4.406
Authors: Faraz A Khan; Paul D Mitchell; Jeremy G Fisher; Eric A Sparks; Tom Jaksic; Christopher Duggan; Daniel H Teitelbaum; Biren P Modi Journal: J Pediatr Surg Date: 2014-11-14 Impact factor: 2.545
Authors: Patrick M Chesley; Sabrina E Sanchez; Lilah Melzer; Assaf P Oron; Simon P Horslen; F Curt Bennett; Patrick J Javid Journal: J Pediatr Gastroenterol Nutr Date: 2016-07 Impact factor: 2.839
Authors: Faraz A Khan; Jeremy G Fisher; Eric A Sparks; Julie Iglesias; David Zurakowski; Biren P Modi; Christopher Duggan; Tom Jaksic Journal: JPEN J Parenter Enteral Nutr Date: 2014-07-02 Impact factor: 4.016